Overview Financials News + Filings Key Docs Charts Transactions Ownership Insiders
|
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| United States | 3,321.0 | 3,161.0 | 3,381.0 | 1,460.3 | 1,323.8 | | 1,754.9 | 1,537.0 |
| Other international | | | | | 864.1 | | 329.4 | 304.8 |
| Canada | 462.0 | 372.0 | 733.0 | 279.0 | 279.0 | | 204.7 | 175.6 |
| India | 531.0 | 441.0 | 504.0 | 178.5 | 137.8 | | 12.3 | |
| Other | 3,508.0 | 3,582.0 | 3,582.0 | 2,445.7 | 1,277.0 | | 1,006.7 | 1,027.1 |
| Total revenues | 7,822.0 | 7,556.0 | 8,200.0 | 4,363.5 | 3,881.7 | -1,082.7 | 3,308.0 | 3,044.5 |
| Revenue growth [+] | 3.5% | -7.9% | 87.9% | 12.4% | -458.5% | -132.7% | 8.7% | 18.6% |
| United States | 5.1% | -6.5% | 131.5% | 10.3% | | | 14.2% | 15.0% |
| Other international | | | | | | | 8.1% | 37.2% |
| Canada | 24.2% | -49.2% | 162.7% | 0.0% | | | 16.6% | 4.9% |
| India | 20.4% | -12.5% | 182.4% | 29.5% | | | | |
| United Kingdom | -4.5% | -16.5% | -5.0% | 11.0% | | | 1.6% | 22.1% |
| Cost of goods sold | 5,453.0 | 5,419.0 | 5,922.0 | 3,129.6 | 2,816.4 | -2,006.9 | 2,260.2 | 2,108.5 |
| Gross profit | 2,369.0 | 2,137.0 | 2,278.0 | 1,233.9 | 1,065.3 | 924.2 | 1,047.8 | 936.0 |
| Gross margin | 30.3% | 28.3% | 27.8% | 28.3% | 27.4% | -85.4% | 31.7% | 30.7% |
| Selling, general and administrative | 1,030.0 | 948.0 | 1,167.0 | 633.2 | 512.5 | 373.6 | 347.4 | 324.5 |
| Research and development | 176.0 | 162.0 | 210.0 | 87.5 | 95.2 | 71.4 | 71.2 | 61.9 |
| Other operating expenses | 287.0 | 282.0 | 238.0 | 39.8 | 36.5 | 22.7 | 21.7 | 22.4 |
| EBITDA [+] | 1,367.0 | 1,218.0 | 1,064.0 | 582.7 | 524.3 | 526.4 | 672.3 | 588.4 |
| EBITDA growth | 12.2% | 14.5% | 82.6% | 11.1% | -0.4% | -21.7% | 14.3% | 20.4% |
| EBITDA margin | 17.5% | 16.1% | 13.0% | 13.4% | 13.5% | -48.6% | 20.3% | 19.3% |
| Depreciation | 204.0 | 191.0 | 163.0 | 69.5 | 66.7 | 47.1 | 43.1 | 38.8 |
| EBITA | 1,163.0 | 1,027.0 | 901.0 | 513.2 | 457.6 | 479.3 | 629.2 | 549.6 |
| EBITA margin | 14.9% | 13.6% | 11.0% | 11.8% | 11.8% | -44.3% | 19.0% | 18.1% |
| Amortization of intangibles | 287.0 | 282.0 | 238.0 | 39.8 | 36.5 | 22.7 | 21.7 | 22.4 |
| EBIT [+] | 876.0 | 745.0 | 663.0 | 473.4 | 421.1 | 456.6 | 607.6 | 527.1 |
| EBIT growth | 17.6% | 12.4% | 40.1% | 12.4% | -7.8% | -24.8% | 15.3% | 20.5% |
| EBIT margin | 11.2% | 9.9% | 8.1% | 10.8% | 10.8% | -42.2% | 18.4% | 17.3% |
| Interest expense | 177.0 | 199.0 | 219.0 | 112.2 | 77.9 | 30.2 | 19.4 | 18.4 |
| Interest expense | 177.0 | 199.0 | 219.0 | 112.2 | 77.9 | 30.2 | 19.4 | 18.4 |
| Other income (expense), net | 38.0 | 11.0 | 3.0 | 6.4 | 8.9 | -13.6 | -2.8 | -0.8 |
| Pre-tax income | 737.0 | 557.0 | 447.0 | 367.6 | 352.1 | 412.8 | 585.4 | 507.9 |
| Income taxes | 172.0 | 145.0 | 120.0 | 75.9 | 89.8 | 99.4 | 186.7 | 156.2 |
| Tax rate | 23.3% | 26.0% | 26.8% | 20.6% | 25.5% | 24.1% | 31.9% | 30.8% |
| Minority interest | 7.0 | -2.0 | | -3.2 | | 8.5 | | |
| Net income | 558.0 | 414.0 | 327.0 | 294.9 | 262.3 | 304.9 | 398.6 | 351.7 |
| Net margin | 7.1% | 5.5% | 4.0% | 6.8% | 6.8% | -28.2% | 12.1% | 11.6% |
| |
| Basic EPS [+] | $2.97 | $2.18 | $1.92 | $3.07 | $2.75 | $3.37 | $4.15 | $3.67 |
| Growth | 36.4% | 13.7% | -37.6% | 11.8% | -18.6% | -18.7% | 13.0% | 19.9% |
| Diluted EPS [+] | $2.97 | $2.17 | $1.84 | $3.06 | $2.73 | $3.35 | $4.11 | $3.63 |
| Growth | 36.4% | 17.9% | -39.6% | 12.0% | -18.4% | -18.6% | 13.2% | 20.3% |
| |
| Dividends per share [+] | $0.48 | $0.48 | $0.48 | $0.48 | $0.44 | $0.36 | $0.28 | $0.20 |
| Growth | 0.0% | 0.0% | 0.0% | 9.1% | 22.2% | 28.6% | 40.0% | 53.8% |
| |
| Shares outstanding (basic) [+] | 187.7 | 189.9 | 170.5 | 96.0 | 95.5 | 90.4 | 96.1 | 95.8 |
| Growth | -1.2% | 11.4% | 77.6% | 0.5% | 5.7% | -5.9% | 0.3% | 0.3% |
| Shares outstanding (diluted) [+] | 188.1 | 190.4 | 177.3 | 96.5 | 96.1 | 91.1 | 97.0 | 96.9 |
| Growth | -1.2% | 7.4% | 83.7% | 0.4% | 5.4% | -6.0% | 0.1% | 0.1% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|